Target intelligence / Profile preview

LysM domain-containing protein (no recognized "2" variant as a single canonical form) (LysM)

Target
LysM
Molecular classification
Other (carbohydrate-binding protein domain; protein domain family)
01

Overview

The **LysM domain (lysin motif)** is a small, conserved protein module (44–65 amino acids) present in a vast number of prokaryotic and eukaryotic proteins[1][2][3]. LysM domains bind non-covalently to *N*-acetylglucosamine-containing polysaccharides such as peptidoglycan (major component of bacterial cell walls) and chitin (in fungi and insects)[1][3]. LysM-containing proteins display a range of biological activities, including roles in bacterial cell wall metabolism, microbial detection in host immunity, plant innate immune signaling, protein display, and cell surface engineering[1][2][3]. In plants, some LysM-domain receptors play key roles in immune recognition and symbiosis. In bacteria, LysM proteins are often involved in cell wall modification and adhesion[2][3]. There is no evidence that "LysM domain containing 2" is a distinct, druggable protein or clinical target in humans. If you have a specific gene symbol (e.g., LYSMD2 in humans), please provide it, as the phrase "LysM domain containing 2" is unspecific and does not map to a known receptor, enzyme, or canonical target for drugs in the current literature.

Other names
LysM motif proteinLysM-containing proteinLysin motif protein
02

Biological functions

Peptidoglycan bindingChitin bindingProtein anchoring to cell wallsDiverse: involved in cell wall metabolism, immune responses in plants, protein display, and cell immobilization

Beyond the preview

Go deeper on LysM domain-containing protein (no recognized "2" variant as a single canonical form) (LysM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LysM domain-containing protein (no recognized "2" variant as a single canonical form) (LysM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call